Invention Grant
- Patent Title: Antibody inhibiting binding of VEGF to NRP1
-
Application No.: US16067958Application Date: 2017-01-05
-
Publication No.: US11008387B2Publication Date: 2021-05-18
- Inventor: Yasufumi Murakami , Hiroyuki Satofuka , Shigeki Mukoubata , Hirotada Akiyama , Tatsuji Kurose , Sae Akao
- Applicant: ORDER-MADE MEDICAL RESEARCH INC. , SANTEN PHARMACEUTICAL CO., LTD.
- Applicant Address: JP Kashiwa; JP Osaka
- Assignee: ORDER-MADE MEDICAL RESEARCH INC.,SANTEN PHARMACEUTICAL CO., LTD.
- Current Assignee: ORDER-MADE MEDICAL RESEARCH INC.,SANTEN PHARMACEUTICAL CO., LTD.
- Current Assignee Address: JP Kashiwa; JP Osaka
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: JPJP2016-001275 20160106
- International Application: PCT/JP2017/000100 WO 20170105
- International Announcement: WO2017/119434 WO 20170713
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/22 ; A61P27/02 ; A61P35/00 ; C12N5/12 ; C12N15/02
Abstract:
An object of the present invention is to provide an antibody against VEGF that inhibits binding of a vascular endothelial growth factor (VEGF) to neuropilin-1 (NRP1). The present invention provides an antibody against VEGF that inhibits binding of VEGF to NRP1.
Public/Granted literature
- US20190322732A1 ANTIBODY INHIBITING BINDING OF VEGF TO NRP1 Public/Granted day:2019-10-24
Information query
